Togo

in page functions
[French]
Togo
Total population (2018) 7,889,756
Birth cohort (2018) 265,547
Surviving Infants (surviving to 1 year per year, 2018) 254,607
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 52/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 78/1000
World Bank Index, IDA (2015) 2.98
Gross Nation Income (per capita US$, 2015) 540
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 40

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Togo

Type of support

Approvals

2001-2023 (US$)
(29 Oct 2018)

Commitments

2001-2023 (US$)
(29 Oct 2018)

Disbursements

2000-2018 (US$)
(29 Oct 2018)

% Disbursed

(29 Oct 2018)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $61,652,661 $76,271,542 $60,195,167
Cash Support (CASHSUPP) $213,000 $213,000 $213,000 100%
Civil Society Organisation support (CSO) $268,155 N/A
Cold Chain Equipment Optimisation Platform (CCEOP) $1,475,593 $1,475,593 $760,568 52%
Health system strengthening (HSS 1) $3,597,010 $3,597,010 $3,597,010 100%
Health system strengthening (HSS 2) $3,788,119 $6,450,000 $1,619,339 43%
HPV Demo (NVS) $357,276 $357,276 $357,779 100%
Immunisation services support (ISS) $2,990,600 $2,990,600 $2,990,600 100%
Injection Safety Devices (NVS) $374,517 $707,517 $405,023 108%
Injection safety support (INS) $317,617 $317,617 $317,617 100%
IPV (NVS) $575,364 $575,364 $362,949 63%
Meningitis A - campaign (NVS) $2,063,527 $2,063,527 $2,063,614 100%
Meningitis A - operational costs (OPC) $1,744,601 $1,744,601 $1,744,601 100%
MR 1st and 2nd dose (NVS) $794,000 N/A
MR-Catch-up campaign (NVS) $2,391,560 $2,391,560 $2,391,560 100%
MR-Catch-up campaign op.costs (OPC) $2,234,499 $2,234,499 $2,234,499 100%
Penta (NVS) $15,576,011 $16,596,511 $15,864,694 102%
Pneumo (NVS) $14,392,731 $21,077,231 $15,242,893 106%
Product Switch Grant (PSG) $71,497 $71,497 $71,497 100%
Rotavirus (NVS) $5,430,250 $7,883,750 $5,539,784 102%
Vaccine Introduction Grant (VIG) $1,107,066 $1,107,066 $1,106,411 100%
Yellow Fever (NVS) $2,951,823 $3,623,323 $3,043,574 103%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Togo DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 90%
M:F sex ratio at birth (2018) 1.02
Household survey: DTP3 coverage for male (2013) 84.20%
Household survey: DTP3 coverage for female (2013) 81.40%
Household survey: Last DTP3 survey (2013) 83%
% districts achieving > 80% DTP3 coverage (2017) 93%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 91%

Breakdown of support

Non-vaccine support Vaccine support
25% 75%
$14,923,297 $45,271,870

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Togo

02 February 2018

Senegal - Anuradha's blog

From adolescence to adulthood: collaborating for the future of global health

On World Cancer Day 2018, Gavi's Deputy CEO Anuradha Gupta looks at how focussing on adolescent health now could help prevent cancer and other non-communicable diseases for generations to come.

14 October 2016

Benin LOGIVAC

Africa takes second “step” toward strengthening supply chain management

New Strategic Training Executive Programme opens at Benin’s LOGIVAC+ Centre, 12 months after similar course offered in Rwanda

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here